NO20024157L - Kasein-avledete peptider og anvendelser derav i terapi - Google Patents
Kasein-avledete peptider og anvendelser derav i terapiInfo
- Publication number
- NO20024157L NO20024157L NO20024157A NO20024157A NO20024157L NO 20024157 L NO20024157 L NO 20024157L NO 20024157 A NO20024157 A NO 20024157A NO 20024157 A NO20024157 A NO 20024157A NO 20024157 L NO20024157 L NO 20024157L
- Authority
- NO
- Norway
- Prior art keywords
- peptides
- casein
- stimulating
- derived
- therapy
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 239000005018 casein Substances 0.000 title abstract 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 title abstract 3
- 235000021240 caseins Nutrition 0.000 title abstract 3
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 230000004936 stimulating effect Effects 0.000 abstract 3
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 210000000601 blood cell Anatomy 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 208000014951 hematologic disease Diseases 0.000 abstract 1
- 230000011132 hemopoiesis Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Marine Sciences & Fisheries (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL13483000A IL134830A0 (en) | 2000-03-01 | 2000-03-01 | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
| PCT/IL2001/000198 WO2001064234A1 (en) | 2000-03-01 | 2001-03-01 | Casein derived peptides and uses thereof in therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20024157D0 NO20024157D0 (no) | 2002-08-30 |
| NO20024157L true NO20024157L (no) | 2002-10-30 |
Family
ID=11073892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20024157A NO20024157L (no) | 2000-03-01 | 2002-08-30 | Kasein-avledete peptider og anvendelser derav i terapi |
Country Status (21)
| Country | Link |
|---|---|
| US (6) | US20020147144A1 (enExample) |
| EP (1) | EP1261360B1 (enExample) |
| JP (1) | JP2003528827A (enExample) |
| KR (1) | KR20030025907A (enExample) |
| CN (1) | CN1427725A (enExample) |
| AT (1) | ATE451929T1 (enExample) |
| AU (1) | AU782662B2 (enExample) |
| BR (1) | BR0109027A (enExample) |
| CA (1) | CA2401550A1 (enExample) |
| CZ (1) | CZ20022915A3 (enExample) |
| DE (1) | DE60140794D1 (enExample) |
| DK (1) | DK1261360T3 (enExample) |
| EA (3) | EA007217B1 (enExample) |
| HU (1) | HUP0301003A3 (enExample) |
| IL (2) | IL134830A0 (enExample) |
| MX (1) | MXPA02008569A (enExample) |
| NO (1) | NO20024157L (enExample) |
| NZ (1) | NZ521016A (enExample) |
| PL (1) | PL361307A1 (enExample) |
| WO (1) | WO2001064234A1 (enExample) |
| ZA (1) | ZA200206842B (enExample) |
Families Citing this family (147)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2458924A1 (en) * | 2001-08-30 | 2003-03-06 | Chay 13 Medical Research Group N.V. | Casein derived peptides and uses thereof in therapy |
| AU2003217337A1 (en) * | 2002-02-06 | 2003-09-02 | University Of North Carolina At Chapel Hill | High-throughput cell identification and isolation method and apparatus |
| EP1359157A1 (en) * | 2002-04-29 | 2003-11-05 | Société des Produits Nestlé S.A. | Metallo-proteinase inhibitory agent |
| KR101188292B1 (ko) * | 2002-11-27 | 2012-10-09 | 디엠아이 바이오사이언시스, 인크 | 인산화 증가로 인한 질병 및 증상의 치료방법 |
| GB0313892D0 (en) * | 2003-06-16 | 2003-07-23 | Hannah Res Inst | Control of lactation |
| CA2558155A1 (en) * | 2004-03-01 | 2005-09-09 | Zvi Sidelman | Casein derived peptides and therapeutic uses thereof |
| BRPI0509541A (pt) | 2004-03-30 | 2007-09-18 | Monsanto Technology Llc | métodos para controlar agentes patógenos de planta utilizando n-fosfonometilglicina |
| WO2005099724A2 (en) * | 2004-04-13 | 2005-10-27 | Parallel Solutions, Inc. | Functionalized water-soluble polyphosphazene and uses thereof as modifiers of biological agents |
| US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| US9801913B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Barrier layer |
| GB0423352D0 (en) | 2004-10-21 | 2004-11-24 | Hannah Res Inst | "Control of mammary cell number" |
| PL1890720T3 (pl) * | 2005-05-02 | 2013-06-28 | Mileutis Ltd | Kompozycje farmaceutyczne zawierające peptydy pochodzące z kazeiny i sposoby ich stosowania |
| ES2319475B1 (es) * | 2005-06-08 | 2010-02-16 | Consejo Superior Investig. Cientificas | Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion. |
| US11266607B2 (en) * | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
| US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
| US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
| US8124721B2 (en) | 2005-10-04 | 2012-02-28 | Inimex Pharmaceuticals Inc. | Peptides for modulating innate immunity |
| US20070086958A1 (en) * | 2005-10-14 | 2007-04-19 | Medafor, Incorporated | Formation of medically useful gels comprising microporous particles and methods of use |
| GB2436328A (en) * | 2006-03-22 | 2007-09-26 | Regen Therapeutics Plc | Peptide derived from colostrinin |
| WO2007110296A1 (en) * | 2006-03-24 | 2007-10-04 | Unilever N.V. | Healthy food product |
| EP1836906B1 (en) * | 2006-03-24 | 2009-07-01 | Unilever N.V. | Healthy food product |
| SG175573A1 (en) * | 2006-10-04 | 2011-11-28 | Inimex Pharmaceuticals Inc | Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| JP5592652B2 (ja) * | 2007-02-05 | 2014-09-17 | ナショナル ユニバーシティ オブ シンガポール | 推定サイトカイニン受容体およびその使用方法 |
| US8097712B2 (en) | 2007-11-07 | 2012-01-17 | Beelogics Inc. | Compositions for conferring tolerance to viral disease in social insects, and the use thereof |
| US20110004019A1 (en) * | 2008-03-12 | 2011-01-06 | Shiseido Company Ltd. | Parakeratosis Inhibitor, Pore-Shrinking Agent, Or Rough Skin Inhibiting/Ameliorating Agent, And External Composition For Skin Containing The Same |
| CA2750462C (en) * | 2009-02-06 | 2014-08-19 | The Procter & Gamble Company | Collapsible water-containing capsules |
| AU2010233097B2 (en) * | 2009-04-10 | 2016-04-07 | Abraxis Bioscience, Llc | Nanoparticle formulations and uses thereof |
| CN102405042A (zh) | 2009-05-04 | 2012-04-04 | 普西维达公司 | 多孔硅药物洗脱颗粒 |
| WO2010135324A1 (en) * | 2009-05-18 | 2010-11-25 | Monsanto Technology Llc | Use of glyphosate for disease suppression and yield enhancement in soybean |
| GB0912481D0 (en) | 2009-07-17 | 2009-08-26 | Reckitt Benckiser Healthcare I | Skincare compositions |
| US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
| US8962584B2 (en) | 2009-10-14 | 2015-02-24 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Compositions for controlling Varroa mites in bees |
| US11000711B2 (en) * | 2009-12-29 | 2021-05-11 | W. R. Grace & Co.-Conn. | Compositions for forming films having a desired degree of obscuration and methods of making and using the same |
| BR112012019631B1 (pt) * | 2010-02-04 | 2019-04-30 | Isp Investments Llc | Composição anidra de filtro solar, método não terapêutico para proteger o cabelo e método para melhorar o valor do fps de um princípio ativo de proteção solar |
| BR112012020705B8 (pt) | 2010-02-18 | 2022-07-05 | Athenix Corp | Molécula de ácido nucleico recombinante, vetor, célula hospedeira microbiana, polipeptídeo recombinante com atividade pesticida, composição, bem como métodos para o controle de uma população de pragas de lepidópteros, para matar uma praga de lepidóptero, para a produção de um polipeptídeo com atividade pesticida, para a proteção de uma planta de uma praga, e para aumentar o rendimento em uma planta |
| MX2012009634A (es) * | 2010-02-18 | 2012-09-28 | Athenix Corp | Genes delta-endotoxinicos axmi218, axmi219, axmi220, axmi226, axmi227, axmi228, axmi229, axmi230, y axmi231 y metodos para sus uso. |
| NZ601784A (en) | 2010-03-08 | 2014-08-29 | Monsanto Technology Llc | Polynucleotide molecules for gene regulation in plants |
| FR2958155B1 (fr) * | 2010-04-02 | 2012-04-20 | Oreal | Composition de decoloration comprenant un sel peroxygene dans une base fortement riche en corps gras |
| WO2011137563A1 (en) | 2010-05-07 | 2011-11-10 | Unilever Plc | High solvent content emulsions |
| WO2011153186A1 (en) | 2010-06-04 | 2011-12-08 | Monsanto Technology Llc | Transgenic brassica event mon 88302 and methods of use thereof |
| WO2012009707A2 (en) | 2010-07-16 | 2012-01-19 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
| MX2013001740A (es) * | 2010-08-19 | 2013-05-20 | Pioneer Hi Bred Int | Nuevo gen de bacillus thuringiensis con actividad lepidoptera |
| BR112013010190B1 (pt) * | 2010-10-28 | 2019-12-31 | Aequus Pharmaceuticals Inc | composição farmacêutica |
| US9757374B2 (en) | 2010-10-28 | 2017-09-12 | Aequus Pharmaceuticals Inc. | Aripiprazole compositions and methods for its transdermal delivery |
| EP2635255B1 (en) | 2010-11-01 | 2019-08-21 | EyePoint Pharmaceuticals US, Inc. | Bioerodible silicon-based devices for delivery of therapeutic agents |
| CA2836911A1 (en) * | 2011-06-04 | 2012-12-13 | Ian S. CURTIS | Potato transformation compositions, systems, methods, microorganisms, and plants |
| AU2012296987A1 (en) * | 2011-08-12 | 2014-02-27 | Bayer Cropscience Nv | Guard cell-specific expression of transgenes in cotton |
| EP2756086B1 (en) | 2011-09-13 | 2018-02-21 | Monsanto Technology LLC | Methods and compositions for weed control |
| US9416363B2 (en) | 2011-09-13 | 2016-08-16 | Monsanto Technology Llc | Methods and compositions for weed control |
| AU2012308686B2 (en) | 2011-09-13 | 2018-05-10 | Monsanto Technology Llc | Methods and compositions for weed control |
| US10806146B2 (en) | 2011-09-13 | 2020-10-20 | Monsanto Technology Llc | Methods and compositions for weed control |
| US10829828B2 (en) | 2011-09-13 | 2020-11-10 | Monsanto Technology Llc | Methods and compositions for weed control |
| US9840715B1 (en) | 2011-09-13 | 2017-12-12 | Monsanto Technology Llc | Methods and compositions for delaying senescence and improving disease tolerance and yield in plants |
| US10760086B2 (en) | 2011-09-13 | 2020-09-01 | Monsanto Technology Llc | Methods and compositions for weed control |
| WO2013040057A1 (en) | 2011-09-13 | 2013-03-21 | Monsanto Technology Llc | Methods and compositions for weed control |
| US9920326B1 (en) | 2011-09-14 | 2018-03-20 | Monsanto Technology Llc | Methods and compositions for increasing invertase activity in plants |
| WO2013052114A1 (en) * | 2011-10-05 | 2013-04-11 | Fmc Corporation | Stabilizer composition of microcrystalline cellulose and carboxymethylcellulose, method for making, and uses |
| US9492363B1 (en) * | 2012-01-16 | 2016-11-15 | American Spraytech, L.L.C. | Aerosol sprayable color composition |
| NZ627242A (en) * | 2012-01-27 | 2016-08-26 | Agile Therapeutics Inc | Transdermal hormone delivery |
| FR2988566B1 (fr) * | 2012-03-28 | 2014-08-08 | Yoplait France | Compositions alimentaires pour stimuler la formation de tissu osseux |
| EP2855680B8 (en) | 2012-05-24 | 2020-04-15 | Monsanto Technology LLC | Compositions and methods for silencing gene expression |
| EP2879715B1 (en) * | 2012-08-03 | 2023-03-29 | MSM Innovations, Inc. | Method and kit for bowel preparation |
| US10752949B2 (en) | 2012-08-14 | 2020-08-25 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| BR112015003354A8 (pt) | 2012-08-14 | 2018-01-16 | 10X Genomics Inc | métodos e composições de microcápsula |
| US10221442B2 (en) | 2012-08-14 | 2019-03-05 | 10X Genomics, Inc. | Compositions and methods for sample processing |
| US11591637B2 (en) | 2012-08-14 | 2023-02-28 | 10X Genomics, Inc. | Compositions and methods for sample processing |
| US10273541B2 (en) | 2012-08-14 | 2019-04-30 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US9701998B2 (en) | 2012-12-14 | 2017-07-11 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10323279B2 (en) | 2012-08-14 | 2019-06-18 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10584381B2 (en) | 2012-08-14 | 2020-03-10 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US9951386B2 (en) | 2014-06-26 | 2018-04-24 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US9617297B2 (en) * | 2012-10-11 | 2017-04-11 | The Regents Of The University Of California | Apoplast wash fluid recovery for improved recombinant endoglucanase extraction in tabacco leaves |
| US10077451B2 (en) | 2012-10-18 | 2018-09-18 | Monsanto Technology Llc | Methods and compositions for plant pest control |
| EP3567116A1 (en) | 2012-12-14 | 2019-11-13 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10533221B2 (en) | 2012-12-14 | 2020-01-14 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US9206436B2 (en) * | 2012-12-20 | 2015-12-08 | Ut-Battelle, Llc | Key gene regulating cell wall biosynthesis and recalcitrance in Populus, gene Y |
| AU2013371825B2 (en) | 2013-01-01 | 2019-10-24 | A.B. Seeds Ltd. | Methods of introducing dsRNA to plant seeds for modulating gene expression |
| US10683505B2 (en) | 2013-01-01 | 2020-06-16 | Monsanto Technology Llc | Methods of introducing dsRNA to plant seeds for modulating gene expression |
| US10000767B2 (en) | 2013-01-28 | 2018-06-19 | Monsanto Technology Llc | Methods and compositions for plant pest control |
| CA2900481A1 (en) | 2013-02-08 | 2014-08-14 | 10X Genomics, Inc. | Polynucleotide barcode generation |
| US8961680B2 (en) * | 2013-03-08 | 2015-02-24 | Tbf Environmental Technology Inc. | Solvent formulations |
| WO2014165108A1 (en) * | 2013-03-12 | 2014-10-09 | Psivida Us, Inc. | Bioerodible silicon-based delivery vehicles for delivery of therapeutic agents |
| EP2971185A4 (en) | 2013-03-13 | 2017-03-08 | Monsanto Technology LLC | Methods and compositions for weed control |
| BR112015022797A2 (pt) | 2013-03-13 | 2017-11-07 | Monsanto Technology Llc | método para controle de ervas daninhas, composição herbicida, cassete de expressão microbiano e método de produção de polinucleotídeo |
| US20140283211A1 (en) | 2013-03-14 | 2014-09-18 | Monsanto Technology Llc | Methods and Compositions for Plant Pest Control |
| CA2904077A1 (en) | 2013-03-15 | 2014-09-25 | Psivida Us, Inc. | Bioerodible silicon-based compositions for delivery of therapeutic agents |
| US8889633B2 (en) | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
| US9138455B2 (en) | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
| US9345741B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof |
| AU2014240095A1 (en) * | 2013-03-15 | 2015-10-08 | Maria Beug-Deeb Inc. Dba T&M Associates | Methods and compositions for cleaning and disinfecting surfaces |
| US9289461B2 (en) * | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
| US9345727B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component and uses thereof |
| US9352020B2 (en) | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
| US10568328B2 (en) | 2013-03-15 | 2020-02-25 | Monsanto Technology Llc | Methods and compositions for weed control |
| CA2817728A1 (en) * | 2013-05-31 | 2014-11-30 | Pharmascience Inc. | Abuse deterrent immediate release formulation |
| US9850496B2 (en) | 2013-07-19 | 2017-12-26 | Monsanto Technology Llc | Compositions and methods for controlling Leptinotarsa |
| MX359191B (es) | 2013-07-19 | 2018-09-18 | Monsanto Technology Llc | Composiciones y métodos para controlar leptinotarsa. |
| PL3054926T3 (pl) * | 2013-10-07 | 2018-12-31 | Bristol-Myers Squibb Holdings Ireland | Leczenie zakażenia wirusem hiv formulacją atazanawiru i kobicystatu |
| UA120426C2 (uk) | 2013-11-04 | 2019-12-10 | Монсанто Текнолоджі Елелсі | Композиція та спосіб для боротьби з членистоногими паразитами та зараженням шкідниками |
| UA119253C2 (uk) | 2013-12-10 | 2019-05-27 | Біолоджикс, Інк. | Спосіб боротьби із вірусом у кліща varroa та у бджіл |
| BR112016016337A2 (pt) | 2014-01-15 | 2017-10-03 | Monsanto Technology Llc | Composição e métodos para controlar crescimento, desenvolvimento ou a capacidade de reprodução de uma planta, e para sensibilizar uma planta para um herbicida inibidor de epsps |
| ES2544153B1 (es) * | 2014-02-24 | 2016-06-06 | Ntd Labs, S.L. | Uso de un hidrolizado de caseína como agente antiviral |
| CN110506752B (zh) | 2014-04-01 | 2022-02-18 | 孟山都技术公司 | 用于控制虫害的组合物和方法 |
| KR102596508B1 (ko) | 2014-04-10 | 2023-10-30 | 10엑스 제노믹스, 인크. | 시약을 캡슐화 및 구획화하기 위한 유체 디바이스, 시스템, 및 방법, 및 이의 응용 |
| EP3158067B1 (en) | 2014-06-23 | 2020-08-12 | Monsanto Technology LLC | Compositions and methods for regulating gene expression via rna interference |
| WO2015200539A1 (en) | 2014-06-25 | 2015-12-30 | Monsanto Technology Llc | Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression |
| KR20170026383A (ko) | 2014-06-26 | 2017-03-08 | 10엑스 제노믹스, 인크. | 핵산 서열의 분석 |
| EP4574974A3 (en) | 2014-06-26 | 2025-10-08 | 10x Genomics, Inc. | Methods of analyzing nucleic acids from individual cells or cell populations |
| US12312640B2 (en) | 2014-06-26 | 2025-05-27 | 10X Genomics, Inc. | Analysis of nucleic acid sequences |
| JP6640826B2 (ja) | 2014-07-08 | 2020-02-05 | ミメディクス グループ インコーポレイテッド | 微粒子化ワルトン膠質 |
| US20160022604A1 (en) * | 2014-07-23 | 2016-01-28 | Cadila Healthcare Limited | Directly compressed ospemifene compositions |
| US10378012B2 (en) | 2014-07-29 | 2019-08-13 | Monsanto Technology Llc | Compositions and methods for controlling insect pests |
| PL3191083T3 (pl) * | 2014-09-11 | 2021-07-12 | Gelita Ag | Cząstki żelatyny/pektyny |
| EP3193613A1 (en) | 2014-09-17 | 2017-07-26 | Lonza Inc. | Activated disinfectant hydrogen peroxide compositions |
| US20160122817A1 (en) | 2014-10-29 | 2016-05-05 | 10X Genomics, Inc. | Methods and compositions for targeted nucleic acid sequencing |
| US9975122B2 (en) | 2014-11-05 | 2018-05-22 | 10X Genomics, Inc. | Instrument systems for integrated sample processing |
| US10471096B2 (en) * | 2015-01-06 | 2019-11-12 | Osamu Yamada | Medicinal composition, blood treatment device, cosmetic, food and drink using combustion synthesis material |
| SG11201705615UA (en) | 2015-01-12 | 2017-08-30 | 10X Genomics Inc | Processes and systems for preparing nucleic acid sequencing libraries and libraries prepared using same |
| UA124255C2 (uk) | 2015-01-22 | 2021-08-18 | Монсанто Текнолоджі Елелсі | Інсектицидна композиція та спосіб боротьби з leptinotarsa |
| US10697000B2 (en) | 2015-02-24 | 2020-06-30 | 10X Genomics, Inc. | Partition processing methods and systems |
| CN107532202A (zh) | 2015-02-24 | 2018-01-02 | 10X 基因组学有限公司 | 用于靶向核酸序列覆盖的方法 |
| EP3262233A1 (en) | 2015-02-25 | 2018-01-03 | The Procter and Gamble Company | Fibrous structures comprising a surface softening composition |
| US20160303043A1 (en) * | 2015-04-16 | 2016-10-20 | Kate Somerville Skincare, LLC | Self-foaming compositions and methods |
| UY36703A (es) | 2015-06-02 | 2016-12-30 | Monsanto Technology Llc | Composiciones y métodos para la administración de un polinucleótido en una planta |
| AU2016270913A1 (en) | 2015-06-03 | 2018-01-04 | Monsanto Technology Llc | Methods and compositions for introducing nucleic acids into plants |
| JP6866343B2 (ja) | 2015-07-10 | 2021-04-28 | ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ | メタセシス化不飽和ポリオールエステルを含む布地ケア組成物 |
| EP4144861B1 (en) | 2015-12-04 | 2024-09-11 | 10X Genomics, Inc. | Methods and compositions for nucleic acid analysis |
| WO2017197343A2 (en) | 2016-05-12 | 2017-11-16 | 10X Genomics, Inc. | Microfluidic on-chip filters |
| WO2017197338A1 (en) | 2016-05-13 | 2017-11-16 | 10X Genomics, Inc. | Microfluidic systems and methods of use |
| AU2017293856B2 (en) | 2016-07-08 | 2020-04-02 | The Gillette Company Llc | Liquid compositions for hair removal devices comprising metathesized unsaturated polyol esters |
| DE102016223333A1 (de) * | 2016-11-24 | 2018-05-24 | Henkel Ag & Co. Kgaa | Alkalische Mittel zum Aufhellen von Haaren enthaltend Oxidationsmittel und spezielle Carbonsäureester als Keratinvernetzer |
| US10011872B1 (en) | 2016-12-22 | 2018-07-03 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10815525B2 (en) | 2016-12-22 | 2020-10-27 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10550429B2 (en) | 2016-12-22 | 2020-02-04 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US12264411B2 (en) | 2017-01-30 | 2025-04-01 | 10X Genomics, Inc. | Methods and systems for analysis |
| EP4310183B1 (en) | 2017-01-30 | 2025-07-09 | 10X Genomics, Inc. | Methods and systems for droplet-based single cell barcoding |
| MA47686A (fr) * | 2017-03-01 | 2021-05-12 | Arena Pharm Inc | Compositions comprenant des agonistes du récepteur pgi2 et procédés de préparation associés |
| US10398670B2 (en) * | 2017-04-24 | 2019-09-03 | Knoze Jr. Corporation | Oral microbiota promotion for oral and/or sinus infections |
| US20180340169A1 (en) | 2017-05-26 | 2018-11-29 | 10X Genomics, Inc. | Single cell analysis of transposase accessible chromatin |
| CN109526228B (zh) | 2017-05-26 | 2022-11-25 | 10X基因组学有限公司 | 转座酶可接近性染色质的单细胞分析 |
| US10471033B2 (en) * | 2017-09-15 | 2019-11-12 | Knoze Jr. Corporation | Oral microbiota promotion for immune system associated inflammations |
| US12151014B2 (en) * | 2017-09-18 | 2024-11-26 | Mast Industries (Far East) Limited | Gloss lip balm formulation |
| WO2019099751A1 (en) | 2017-11-15 | 2019-05-23 | 10X Genomics, Inc. | Functionalized gel beads |
| US10829815B2 (en) | 2017-11-17 | 2020-11-10 | 10X Genomics, Inc. | Methods and systems for associating physical and genetic properties of biological particles |
| SG11202009889VA (en) | 2018-04-06 | 2020-11-27 | 10X Genomics Inc | Systems and methods for quality control in single cell processing |
| US20220330599A1 (en) * | 2019-09-16 | 2022-10-20 | Kiverdi, Inc. | Microbial Protein Hydrolysate Compositions and Methods of Making Same |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3764670A (en) * | 1970-10-28 | 1973-10-09 | Ministry Of Agriculture | Polypeptidic anti-biotic substances derived from casein |
| US3778426A (en) * | 1970-12-16 | 1973-12-11 | Research Corp | Therapeutically useful polypeptides |
| US4636384A (en) * | 1982-06-03 | 1987-01-13 | Stolle Research & Development Corporation | Method for treating disorders of the vascular and pulmonary systems |
| US4959455A (en) * | 1986-07-14 | 1990-09-25 | Genetics Institute, Inc. | Primate hematopoietic growth factors IL-3 and pharmaceutical compositions |
| JP2631470B2 (ja) * | 1987-05-15 | 1997-07-16 | 雪印乳業株式会社 | 感染防御剤 |
| US5344820A (en) * | 1987-05-15 | 1994-09-06 | Snow Brand Milk Products Co., Ltd. | Infection protectant |
| JP2805490B2 (ja) * | 1989-02-07 | 1998-09-30 | 雪印乳業株式会社 | 細菌毒素中和剤 |
| US5514646A (en) * | 1989-02-09 | 1996-05-07 | Chance; Ronald E. | Insulin analogs modified at position 29 of the B chain |
| FR2686085B1 (fr) * | 1992-01-10 | 1995-08-04 | Agronomique Inst Nat Rech | Peptides representant des fragments du cmp, anticorps diriges contre lesdits peptides, et leurs utilisations. |
| GB9310472D0 (en) * | 1993-05-20 | 1993-07-07 | Univ Warwick | Phenylalanine-free protein and dna coding thereof |
| TW282398B (enExample) * | 1993-12-22 | 1996-08-01 | Bristol Myers Squibb Co | |
| US5506209A (en) * | 1994-05-26 | 1996-04-09 | Abbott Laboratories | Product for inhibition of infection of mammalian cells by respiratory syncytial virus |
| US5538952A (en) * | 1994-05-26 | 1996-07-23 | Abbott Laboratories | Inhibition of infection of mammalian cells by respiratory syncytial virus |
| US5707968A (en) * | 1994-05-26 | 1998-01-13 | Abbott Laboratories | Inhibition of attachment of H.influenzae to human cells |
| US5712250A (en) * | 1994-09-16 | 1998-01-27 | Abbott Laboratories | Product for inhibition of human rotavirus infection |
| KR0140248B1 (ko) * | 1995-03-23 | 1998-06-15 | 한상기 | 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법 |
| US5985275A (en) * | 1995-04-12 | 1999-11-16 | New York Blood Center | β-Lactoglobulin modified with aromatic anhydride compound for preventing HIV infection |
| US6570060B2 (en) * | 1995-05-16 | 2003-05-27 | Mclachlan Corran Norman Stuart | Milk lacking β-casein A1 |
| KR100221124B1 (ko) * | 1996-09-23 | 1999-10-01 | 한상기 | 신규한 카제인 및 그 제조방법 |
| US5830434A (en) * | 1997-02-26 | 1998-11-03 | Medical University Of South Carolina Foundation For Research Development | Methods of treating non-insulin dependent diabetes mellitus with pancreatic polypeptide |
| NZ332993A (en) * | 1997-03-21 | 2000-01-28 | Snow Brand Milk Products Co Ltd | Iron-casein complex hydrolyzate and process for the production thereof |
| US6358508B1 (en) * | 1997-06-11 | 2002-03-19 | Human Genome Sciences, Inc. | Antibodies to human tumor necrosis factor receptor TR9 |
| JP4459435B2 (ja) * | 1997-08-29 | 2010-04-28 | ナラン ウトゥク | 新規ｔ細胞膜蛋白質（ｔｉｒｃ７）、ペプチドおよびそれに由来する抗体ならびにその使用 |
| AUPP051497A0 (en) * | 1997-11-24 | 1997-12-18 | University Of Melbourne, The | Antimicrobial peptides |
| US5985575A (en) * | 1998-05-20 | 1999-11-16 | Wisconsin Alumni Research Foundation | Tethered function assay for protein function |
| US6570606B1 (en) * | 1998-05-29 | 2003-05-27 | 3Com Corporation | Method and apparatus for controlling transmission of media signals over a data network in response to triggering events at participating stations |
| CN1230444C (zh) * | 1998-11-16 | 2005-12-07 | 德克萨斯州立大学董事会 | 含有hiv细胞毒t淋巴细胞表位的hiv多肽或肽或其多聚核苷酸表达构建体的用途 |
| GB9927603D0 (en) * | 1999-11-22 | 2000-01-19 | Nestle Sa | Use of a milk protein hydrolysate in the treatment of diabetes |
| IL138946A0 (en) * | 2000-10-11 | 2001-11-25 | Compugen Ltd | Method for the identification of peptides and proteins |
| RU2008116721A (ru) * | 2005-09-28 | 2009-11-10 | ДиЭнПи КЭНАДА ИНК. (CA) | Комбинация полихитозамина и фибрата для предотвращения и лечения гиперлипидемии |
| US8865876B2 (en) * | 2008-06-02 | 2014-10-21 | California Institute Of Technology | Engineered lectin oligomers with antiviral activity |
-
2000
- 2000-03-01 IL IL13483000A patent/IL134830A0/xx unknown
-
2001
- 2001-03-01 JP JP2001563131A patent/JP2003528827A/ja active Pending
- 2001-03-01 HU HU0301003A patent/HUP0301003A3/hu unknown
- 2001-03-01 CZ CZ20022915A patent/CZ20022915A3/cs unknown
- 2001-03-01 PL PL36130701A patent/PL361307A1/xx unknown
- 2001-03-01 EA EA200401467A patent/EA007217B1/ru not_active IP Right Cessation
- 2001-03-01 NZ NZ521016A patent/NZ521016A/en unknown
- 2001-03-01 EP EP01908105A patent/EP1261360B1/en not_active Expired - Lifetime
- 2001-03-01 BR BR0109027-5A patent/BR0109027A/pt not_active IP Right Cessation
- 2001-03-01 DE DE60140794T patent/DE60140794D1/de not_active Expired - Lifetime
- 2001-03-01 CA CA002401550A patent/CA2401550A1/en not_active Abandoned
- 2001-03-01 AT AT01908105T patent/ATE451929T1/de not_active IP Right Cessation
- 2001-03-01 MX MXPA02008569A patent/MXPA02008569A/es not_active Application Discontinuation
- 2001-03-01 WO PCT/IL2001/000198 patent/WO2001064234A1/en not_active Ceased
- 2001-03-01 EA EA200200820A patent/EA005579B1/ru not_active IP Right Cessation
- 2001-03-01 DK DK01908105.8T patent/DK1261360T3/da active
- 2001-03-01 AU AU35962/01A patent/AU782662B2/en not_active Ceased
- 2001-03-01 CN CN01808959A patent/CN1427725A/zh active Pending
- 2001-08-30 US US09/942,121 patent/US20020147144A1/en not_active Abandoned
-
2002
- 2002-08-19 IL IL151351A patent/IL151351A/en active IP Right Grant
- 2002-08-27 ZA ZA200206842A patent/ZA200206842B/en unknown
- 2002-08-29 EA EA200400376A patent/EA007814B1/ru not_active IP Right Cessation
- 2002-08-30 NO NO20024157A patent/NO20024157L/no not_active Application Discontinuation
- 2002-08-31 KR KR10-2002-7011450A patent/KR20030025907A/ko not_active Ceased
-
2006
- 2006-09-08 US US11/518,400 patent/US7741274B2/en not_active Expired - Lifetime
-
2007
- 2007-10-31 US US11/982,369 patent/US20090192081A1/en not_active Abandoned
-
2010
- 2010-04-22 US US12/764,996 patent/US20100298216A1/en not_active Abandoned
- 2010-07-28 US US12/844,834 patent/US20100317601A1/en not_active Abandoned
-
2012
- 2012-09-05 US US13/603,428 patent/US8735348B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20024157L (no) | Kasein-avledete peptider og anvendelser derav i terapi | |
| WO2005081628A3 (en) | Casein derived peptides and therapeutic uses thereof | |
| ATE314095T1 (de) | Virusähnliche partikel zur induktion von autoantikörpern | |
| ATE486614T1 (de) | Zusammensetzungen zum einsatz in einer gentherapie zur behandlung von hämophilie | |
| ES2187798T3 (es) | Procedimiento de conservacion de virus recombinantes infecciosos, suspension acuosa viral y su utilizacion como medicamento. | |
| DE69838986D1 (de) | Polypeptide, deren herstellung und verwendung | |
| FI971613A7 (fi) | Defektiivisiä adenoviruksia, jotka käsittävät terapeuttisen geenin ja immunoprotektiivisen geenin | |
| TR200102308T2 (tr) | Yüzey etkinliğine sahip yapay peptidler ve bunların yapay yüzey aktif maddelerin hazırlanmasında kullanımı | |
| PL375113A1 (en) | Casein derived peptides and uses thereof in therapy | |
| WO2002086100A3 (en) | Expression of core-glycosylated hcv envelope proteins in yeast | |
| DK0750672T3 (da) | DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse | |
| BR0009170A (pt) | ácidos nucléicos akt, polipeptìdeos e uso dos mesmos | |
| NZ508505A (en) | Treatment of wounds using an Egr-1 transcription factor polypeptide | |
| NO971247D0 (no) | Defektive, rekombinante adenoviruser med inaktivt IVa2-gen | |
| WO2001045738A3 (en) | Use of heat shock proteins to enhance production of chemokines by a cell | |
| DE3769497D1 (de) | Mittel zur bekaempfung von phytopathogenen mikroben. | |
| AU2003253888A8 (en) | Combination therapies with l-fmau for the treatment of hepatitis b virus infection | |
| ATE386542T1 (de) | Mittel zur stimulation des immunsystems | |
| ATE383866T1 (de) | Antiproliferative und antivirale proteine und peptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |